Medicare Enrolled
Dr. Monte Jones, MD
Medical Oncology · McKinney, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jones from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jones? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jones
Dr. Monte Jones is a medical oncology in McKinney, TX, with 19 years in practice. Based on federal Medicare data, Dr. Jones performed 73,688 Medicare services across 2,662 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jones received a total of $3,029 from 39 pharmaceutical and/or device companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jones is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 13% volume in TX$ $3,029 industry payments
Medicare Practice Summary
Medicare Utilization ↗73,688
Medicare services
Top 13% in TX for medical oncology
2,662
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,878 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 20,800 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 13,605 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 11,200 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 6,800 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 5,250 | $0 | $5 |
| Immune globulin infusion (Octagam) | 3,721 | $33 | $233 |
| Denosumab injection (Prolia/Xgeva) | 2,520 | $18 | $65 |
| Dexamethasone injection (steroid) | 1,126 | $0 | $1 |
| Blood draw (venipuncture) | 982 | $8 | $20 |
| Complete blood count (CBC) with differential | 837 | $8 | $36 |
| Comprehensive metabolic blood panel | 788 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 670 | $0 | $24 |
| Office visit, established patient (30-39 min) | 496 | $90 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 450 | $1 | $114 |
| Ferritin level test (iron stores) | 387 | $13 | $60 |
| Iron level test | 386 | $6 | $27 |
| Iron binding capacity test | 386 | $9 | $35 |
| Injection of additional new drug or substance into vein | 304 | $12 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 193 | $97 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 185 | $48 | $313 |
| Injection, zoledronic acid, 1 mg | 181 | $7 | $431 |
| Injection, carboplatin, 50 mg | 163 | $2 | $300 |
| Lactate dehydrogenase (enzyme) level | 144 | $6 | $31 |
| Drug injection, under skin or into muscle | 139 | $10 | $96 |
| Hospital follow-up visit, moderate complexity | 139 | $60 | $247 |
| Ct scan of chest with contrast | 131 | $44 | $821 |
| Microscopic examination for white blood cells with manual cell count | 127 | $4 | $22 |
| Complete blood count (CBC), automated | 127 | $6 | $34 |
| CT scan of abdomen and pelvis with contrast | 122 | $163 | $1,067 |
| Magnesium level test | 97 | $7 | $29 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 93 | $272 | $2,762 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $53 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 81 | $16 | $100 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 73 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 68 | $1,106 | $4,802 |
| Administration of chemotherapy into vein, each additional hour | 64 | $19 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 63 | $48 | $344 |
| Infusion, normal saline solution , 1000 cc | 60 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 59 | $22 | $157 |
| PSA test (prostate cancer screening) | 58 | $18 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | $23 | $145 |
| Red blood count automated, with additional calculations | 48 | $5 | $26 |
| Injection, diphenhydramine hcl, up to 50 mg | 46 | $1 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 42 | $132 | $3,675 |
| CT scan of chest, without contrast | 36 | $46 | $686 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 35 | $178 | $700 |
| Unclassified drugs | 34 | $1 | $8 |
| New patient office visit (45-59 min) | 31 | $108 | $565 |
| Infusion into a vein for hydration, 31-60 minutes | 30 | $24 | $256 |
| Infusion into a vein for hydration, each additional hour | 24 | $9 | $75 |
| Irrigation of implanted venous access drug delivery device | 23 | $17 | $114 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $19 |
| Injection of drug or substance into vein | 21 | $21 | $247 |
| Initial hospital admission, moderate complexity | 21 | $97 | $470 |
| Urinalysis with microscopic exam | 20 | $3 | $28 |
| Ct scan of abdomen and pelvis without contrast | 14 | $81 | $560 |
| Office visit, established patient (20-29 min) | 14 | $60 | $250 |
| Ct scan of soft tissue of neck with contrast | 12 | $56 | $658 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
87.0% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,029
Total received (2018-2024)
Avg $433/year across 7 years
Bottom 46% in TX for medical oncology
39
Companies
148
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,960 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,498
2023$963
2022$314
2021$43
2020$45
2019$50
2018$115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$385
Novartis Pharmaceuticals Corporation
$328
Celgene Corporation
$215
Merck Sharp & Dohme LLC
$169
PharmaEssentia USA Corporation
$167
GENZYME CORPORATION
$160
Eisai Inc.
$160
Amgen Inc.
$137
SOBI, INC
$128
Gilead Sciences, Inc.
$111
Lilly USA, LLC
$98
Takeda Pharmaceuticals U.S.A., Inc.
$97
PFIZER INC.
$77
ABBVIE INC.
$66
E.R. Squibb & Sons, L.L.C.
$66
Janssen Biotech, Inc.
$61
EMD Serono, Inc.
$56
Astellas Pharma US Inc
$51
Daiichi Sankyo Inc.
$50
Regeneron Healthcare Solutions, Inc.
$49
GlaxoSmithKline, LLC.
$41
Acrotech Biopharma LLC
$38
Merck Sharp & Dohme Corporation
$31
BeiGene USA, Inc.
$28
GE HealthCare
$21
TESARO, Inc.
$20
EISAI INC.
$19
Alexion Pharmaceuticals, Inc.
$19
Genentech USA, Inc.
$19
Pharmacosmos Therapeutics Inc.
$19
JAZZ PHARMACEUTICALS INC.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Seattle Genetics, Inc.
$18
Blueprint Medicines Corporation
$17
Agios Pharmaceuticals, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$15
Medtronic USA, Inc.
$14
ARRAY BIOPHARMA INC
$12
Allergan Inc.
$11
Top 3 companies account for 30.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · ALUNBRIG · AYVAKIT · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · CABLIVI · CALQUENCE · DARZALEX · DOPTELET · Doptelet · ENHERTU · ENJAYMO · EPKINLY · Enhertu · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pomalyst · REBLOZYL · RYBREVANT · SARCLISA · SYLVANT · TABRECTA · TECENTRIQ · TEVIMBRA · ULTOMIRIS · VENCLEXTA · VERZENIO · VIBERZI · VONJO · VONVENDI · VPRIV · Vanflyta · XALKORI · XTANDI · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
25
Per 100K population
2.2
County median income
$117,588
Nearest hospital
MEDICAL CENTER OF MCKINNEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jones is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jones experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Jones performed 20,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jones receive payments from pharmaceutical companies?
Yes. Dr. Jones received a total of $3,029 from 39 companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jones's costs compare to other medical oncologys in McKinney?
Dr. Jones's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jones) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in McKinney
Browse medical oncologys in McKinney ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in TX
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in TX
Which TX medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology